Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36776 - 36800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	CGNL1	84952	upregulated	entinostat results in increased expression of CGNL1 mRNA	15q21.3	A21037
Entinostat	Investigational	CGREF1	10669	upregulated	entinostat results in increased expression of CGREF1 mRNA	2p23.3	A21035
Entinostat	Investigational	CHAC1	79094	downregulated	entinostat results in decreased expression of CHAC1 mRNA	15q15.1	A21035
Entinostat	Investigational	CHAC1	79094	upregulated	entinostat results in increased expression of CHAC1 mRNA	15q15.1	A21037
Entinostat	Investigational	CHAC2	494143	upregulated	entinostat results in increased expression of CHAC2 mRNA	2p16.2	A21037
Entinostat	Investigational	CHCHD10	400916	upregulated	entinostat results in increased expression of CHCHD10 mRNA	22q11.23	A21037 A21035
Entinostat	Investigational	CHGA	1113	upregulated	entinostat results in increased expression of CHGA mRNA	14q32.12	A21037
Entinostat	Investigational	CHODL	140578	upregulated	entinostat results in increased expression of CHODL mRNA	21q21.1	A21037
Entinostat	Investigational	CHP2	63928	upregulated	entinostat results in increased expression of CHP2 mRNA	16p12.2	A21037
Entinostat	Investigational	CHRDL1	91851	upregulated	entinostat results in increased expression of CHRDL1 mRNA	Xq23	A21035
Entinostat	Investigational	CHRM3	1131	upregulated	entinostat results in increased expression of CHRM3 mRNA	1q43	A21037
Entinostat	Investigational	CHRNA3	1136	upregulated	entinostat results in increased expression of CHRNA3 mRNA	15q25.1	A21037
Entinostat	Investigational	CHRNA9	55584	upregulated	entinostat results in increased expression of CHRNA9 mRNA	4p14	A21035
Entinostat	Investigational	CHRNB1	1140	upregulated	entinostat results in increased expression of CHRNB1 mRNA	17p13.1	A21035
Entinostat	Investigational	CHRNB4	1143	upregulated	entinostat results in increased expression of CHRNB4 mRNA	15q25.1	A21037
Entinostat	Investigational	CHST15	51363	upregulated	entinostat results in increased expression of CHST15 mRNA	10q26.13	A21037
Entinostat	Investigational	CHST2	9435	upregulated	entinostat results in increased expression of CHST2 mRNA	3q24	A21035
Entinostat	Investigational	CHST4	10164	upregulated	entinostat results in increased expression of CHST4 mRNA	16q22.2	A21037
Entinostat	Investigational	CHST9	83539	upregulated	entinostat results in increased expression of CHST9 mRNA	18q11.2	A21037
Entinostat	Investigational	CILP2	148113	upregulated	entinostat results in increased expression of CILP2 mRNA	19p13.11	A21035
Entinostat	Investigational	CITED2	10370	upregulated	entinostat results in increased expression of CITED2 mRNA	6q24.1	A21037 A21035
Entinostat	Investigational	CLASP2	23122	downregulated	entinostat results in decreased expression of CLASP2 mRNA	3p22.3	A21035
Entinostat	Investigational	CLCNKB	1188	upregulated	entinostat results in increased expression of CLCNKB mRNA	1p36.13	A21035
Entinostat	Investigational	CLDN1	9076	upregulated	entinostat results in increased expression of CLDN1 mRNA	3q28	A21037
Entinostat	Investigational	CLDN10	9071	upregulated	entinostat results in increased expression of CLDN10 mRNA	13q32.1	A21035

Displaying entries 36776 - 36800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability